These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29025395)

  • 1. Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia.
    Song JU; Park HK; Kang HK; Lee J
    BMC Infect Dis; 2017 Oct; 17(1):681. PubMed ID: 29025395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?].
    Torres Bonafonte OH; Gil Olivas E; Pérez Macho E; Pacho Pacho C; Mateo Roca M; Casademont Pou J; Ruiz Hidalgo D
    Emergencias; 2017 Oct; 29(5):306-312. PubMed ID: 29077289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens.
    Wang PH; Wang HC; Cheng SL; Chang HT; Laio CH
    J Formos Med Assoc; 2016 May; 115(5):356-63. PubMed ID: 25944735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with hemodialysis-associated pneumonia compared to patients with non-hemodialysis community-onset pneumonia.
    Lee JH; Moon JC
    Respir Med; 2016 Feb; 111():84-90. PubMed ID: 26777263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Arch Intern Med; 2008 Nov; 168(20):2205-10. PubMed ID: 19001196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
    Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
    Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia?
    Kawasaki S; Aoki N; Kikuchi H; Nakayama H; Saito N; Shimada H; Miyazaki S; Sakai S; Suzuki M; Narita I
    J Infect Chemother; 2011 Oct; 17(5):640-5. PubMed ID: 21369775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
    Schreiber MP; Chan CM; Shorr AF
    J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.
    Shorr AF; Zilberberg MD; Reichley R; Kan J; Hoban A; Hoffman J; Micek ST; Kollef MH
    Clin Infect Dis; 2012 Jan; 54(2):193-8. PubMed ID: 22109951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factor Evaluation for Methicillin-Resistant
    Lewis PO
    Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia.
    Wang PH; Wang HC
    BMC Infect Dis; 2016 Aug; 16():377. PubMed ID: 27502599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: Evaluation of PES pathogens.
    Ishida T; Ito A; Washio Y; Yamazaki A; Noyama M; Tokioka F; Arita M
    J Infect Chemother; 2017 Jan; 23(1):23-28. PubMed ID: 27729192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.
    Jeong BH; Koh WJ; Yoo H; Park HY; Suh GY; Chung MP; Kwon OJ; Jeon K
    Respiration; 2014; 88(3):190-8. PubMed ID: 24994099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
    Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V
    Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective.
    Aliberti S; Cilloniz C; Chalmers JD; Zanaboni AM; Cosentini R; Tarsia P; Pesci A; Blasi F; Torres A
    Thorax; 2013 Nov; 68(11):997-9. PubMed ID: 23774884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia.
    Falcone M; Russo A; Giannella M; Cangemi R; Scarpellini MG; Bertazzoni G; Alarcón JM; Taliani G; Palange P; Farcomeni A; Vestri A; Bouza E; Violi F; Venditti M
    PLoS One; 2015; 10(4):e0119528. PubMed ID: 25860142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.